Medulloblastoma on the Move: How Tumor Cells Colonize the Leptomeninges – and How to Stop Them
Open Access
- 31 October 2026
- journal article
- review article
- Published by Springer Nature in Cellular and Molecular Bioengineering
- p. 1-10
Abstract
No abstract availableKeywords
Funding Information
- Foundation for the National Institutes of Health (P30CA013696)
- Foundation for the National Institutes of Health (U01-CA253547)
- Foundation for the National Institutes of Health (R01-CA159859)
- Foundation for the National Institutes of Health (R35-NS122339)
- William's Superhero Fund
This publication has 49 references indexed in Scilit:
- Therapeutic radiation drives leptomeningeal dissemination of medulloblastoma through an innate immune processDevelopmental Cell, 2025
- Leveraging Molecular and Immune-Based Therapies in Leptomeningeal MetastasesCNS Drugs, 2022
- Comparison of hypothyroidism, growth hormone deficiency, and adrenal insufficiency following proton and photon radiotherapy in children with medulloblastomaJournal of Neuro-Oncology, 2021
- Medulloblastoma uses GABA transaminase to survive in the cerebrospinal fluid microenvironment and promote leptomeningeal disseminationCell Reports, 2021
- Single-Cell Transcriptomic Analyses of the Developing Meninges Reveal Meningeal Fibroblast Diversity and FunctionDevelopmental Cell, 2020
- Developmental biology of the meningesGenesis, 2019
- A Hematogenous Route for Medulloblastoma Leptomeningeal MetastasesCell, 2018
- Chemotherapy for children with medulloblastomaCochrane Database of Systematic Reviews, 2015
- The Warburg effect in tumor progression: Mitochondrial oxidative metabolism as an anti-metastasis mechanismCancer Letters, 2015
- The intracranial arachnoid materChild's Nervous System, 2012